MET-097i’s mid-stage performance “bodes well” for Pfizer’s buyout bid for Metsera, according to BMO Capital Markets, a deal ...

Drugs like Ozempic and Wegovy, already popular for diabetes and weight loss, may also lower the risk of some cancers, ...

A global analysis finds falling cancer mortality rates in higher-income countries alongside climbing rates in lower-income ...

Much of this comes from low-quality sources like white rice, milled whole grains, and added sugar -- associated with ...

Many of MAHA’s regulatory interventions come at great cost to companies and consumers with little or no health benefit, ...

Patients with chronic liver disease (MASLD) who also have high blood pressure, prediabetes or diabetes, or low HDL cholesterol face the greatest risk. More than one in three people worldwide live with ...

Novo Nordisk's Wegovy, especially at higher doses, rivals Eli Lilly's Zepbound in weight loss. Read why NVO stock is a Strong ...

Soda might taste like a treat, but a growing body of research and expert opinion suggests that one fizzy drink—or more—can carry far more than just empty calories. From weight gain and tooth decay to ...

Legislation pending in Congress would eliminate discriminatory rules that bar anti-obesity medications from the same coverage ...

Navajo Tribe President Ben Shelly signs the Healthy Diné Nation Act into law in 2014. The Act imposed a 2% tax on unhealthy ...